GLI1 and prostate carcinoma: In prostate cancer cells, silencing METTL3 reduces the m6A modification of Gli1, an important component of Hedgehog pathway, and reduces the expression of Gli1, as well as the expression of downstream of hedgehog pathway, which promotes tumor cell apoptosis [52].